About

glp1.blog is a twice weekly newsletter about the business of GLP-1 drugs: pricing, supply, policy, and the companies fighting over the biggest drug market in a generation. Every edition is published here as a permanent post.

TODO: who writes this, why it exists, and how to get in touch.

glp1.blog is business journalism, not medical advice. Talk to a licensed clinician about your health.